BDBM39734 2-(3-chlorophenyl)-5-methyl-N-phenyl-3-pyrazolamine::2-(3-chlorophenyl)-5-methyl-N-phenyl-pyrazol-3-amine::2-(3-chlorophenyl)-5-methyl-N-phenylpyrazol-3-amine::MLS000564424::SMR000151947::[2-(3-chlorophenyl)-5-methyl-pyrazol-3-yl]-phenyl-amine::cid_2356925

SMILES O=C(N[C@@H](c1ccccc1)c1ccc(C2CC2)c(F)n1)[C@@H]1C[C@@H](F)CN1C(=O)COCCOCCOCCOCCOCC(=O)N1C[C@H](F)C[C@H]1C(=O)N[C@@H](c1ccccc1)c1ccc(C2CC2)c(F)n1

InChI Key InChIKey=PRVLPXAOEPGYCT-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39734   

TargetGlycogen [starch] synthase, muscle(Human)
Maze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 39734BDBM39734(US20260098025, Compound 10)
Affinity DataIC50: 14.4nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2026
Entry Details
US Patent